🇺🇸 FDA
Pipeline program

INCLISIRAN, -

CKJX839C12001B

Phase 3 small_molecule active

Quick answer

INCLISIRAN, - for Familial hypercholsterolemia is a Phase 3 program (small_molecule) at Novartis Ophthalmics Europe with 1 ClinicalTrials.gov record(s).

Program details

Company
Novartis Ophthalmics Europe
Indication
Familial hypercholsterolemia
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials